Startseite Historical and cross-cultural perspectives on Parkinson’s disease
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Historical and cross-cultural perspectives on Parkinson’s disease

  • Lee Xenakis Blonder EMAIL logo
Veröffentlicht/Copyright: 8. Mai 2018
Journal of Complementary and Integrative Medicine
Aus der Zeitschrift Journal of Complementary and Integrative Medicine Band 15 Heft 3

Abstract

Parkinson’s disease (PD) is a common neurodegenerative disorder, affecting up to 10 million people worldwide according to the Parkinson’s Disease Foundation. Epidemiological and genetic studies show a preponderance of idiopathic cases and a subset linked to genetic polymorphisms of a familial nature. Traditional Chinese medicine and Ayurveda recognized and treated the illness that Western Medicine terms PD millennia ago, and descriptions of Parkinson’s symptomatology by Europeans date back 2000 years to the ancient Greek physician Galen. However, the Western nosological classification now referred to in English as “Parkinson’s disease” and the description of symptoms that define it, are accredited to British physician James Parkinson, who in 1817 authored The Shaking Palsy. Later in the nineteenth century, French neurologist Jean-Martin Charcot re-labeled paralysis agitans “Parkinson’s disease” and over a century of scientific research ensued. This review discusses European, North American, and Asian contributions to the understanding and treatment of PD from ancient times through the twentieth century.

Keywords: alternative medicine; ayurvedic medicine; history of medicine; Parkinson’s disease; therapeutics; traditional Chinese medicine

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

[1] Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Move Disorders off J Move Disord Soc. 2015;30:1591–601. PubMed PMID: 26474316.10.1002/mds.26424Suche in Google Scholar PubMed

[2] McMenemey W. James Parkinson 1755–1824: a biographical essay. In: Critchley M, editor. James Parkinson. London: Macmillan, 1955: 1–143.Suche in Google Scholar

[3] Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely, and Jones, 1817.Suche in Google Scholar

[4] Critchley M. James Parkinson. London: McMillan, 1955.Suche in Google Scholar

[5] Goetz CG. Charcot on Parkinson’s disease. Move Disorders off J Move Disord Soc. 1986;1:27–32. PubMed PMID: 3332804.10.1002/mds.870010104Suche in Google Scholar PubMed

[6] Blonder LX, Slevin JT. Emotional dysfunction in Parkinson’s disease. Behav Neurol. 2011 Jan 1;24:201–17. PubMed PMID: 21876260. Pubmed Central PMCID: 3177157. Epub 2011/08/31.eng.10.1155/2011/143857Suche in Google Scholar PubMed

[7] Bereczki D. The description of all four cardinal signs of Parkinson’s disease in a Hungarian medical text published in 1690. Parkinsonism Relat Disord. 2010 May;16:290–93. PubMed PMID: 19948422.10.1016/j.parkreldis.2009.11.006Suche in Google Scholar PubMed

[8] Stern G. Did parkinsonism occur before 1817?. J Neurol Neurosurg Psychiatry. 1989 Jun;52:11–12.10.1136/jnnp.52.Suppl.11Suche in Google Scholar

[9] Zhang ZX, Dong ZH, Roman GC. Early descriptions of Parkinson disease in ancient China. Arch Neurol. 2006 May;63:782–84. PubMed PMID: 16682554.10.1001/archneur.63.5.782Suche in Google Scholar PubMed

[10] Zheng GQ. Therapeutic history of Parkinson’s disease in Chinese medical treatises. J Altern Complementary Med. 2009 Nov;15:1223–30. PubMed PMID: 19922254.10.1089/acm.2009.0101Suche in Google Scholar PubMed

[11] Lee SH, Lim S. Clinical effectiveness of acupuncture on Parkinson disease: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2017 Jan;96:e5836. PubMed PMID: 28099340. Pubmed Central PMCID: 5279085.10.1097/MD.0000000000005836Suche in Google Scholar PubMed PubMed Central

[12] Tian T, Sun Y, Wu H, Pei J, Zhang J, Zhang Y, et al. Acupuncture promotes mTOR-independent autophagic clearance of aggregation-prone proteins in mouse brain. Sci Rep. 2016 Jan 21;6:19714. PubMed PMID: 26792101. Pubmed Central PMCID: 4726430.10.1038/srep19714Suche in Google Scholar PubMed PubMed Central

[13] Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J, et al. Tai chi and postural stability in patients with Parkinson’s disease. N Engl J Med. 2012 Feb 09;366:511–19. PubMed PMID: 22316445. Pubmed Central PMCID: 3285459.10.1056/NEJMoa1107911Suche in Google Scholar PubMed PubMed Central

[14] Yang Y, Qiu WQ, Hao YL, Lv ZY, Jiao SJ, Teng JF. The efficacy of traditional Chinese medical exercise for Parkinson’s disease: a systematic review and meta-analysis. PLoS One. 2015;10:e0122469. PubMed PMID: 25830664. Pubmed Central PMCID: 4382160.10.1371/journal.pone.0122469Suche in Google Scholar

[15] Cheung F. TCM: made in China. Nature. 2011 Dec 22;480:S82–3. PubMed PMID: 22190085.10.1038/480S82aSuche in Google Scholar PubMed

[16] Zijlstra FJ, Van Den Berg-De Lange I, Huygen FJ, Klein J. Anti-inflammatory actions of acupuncture. Mediators Inflamm. 2003 Apr;12:59–69. PubMed PMID: 12775355. Pubmed Central PMCID: 1781596.10.1080/0962935031000114943Suche in Google Scholar PubMed

[17] Ye Y, Zhu W, Wang XR, Yang JW, Xiao LY, Liu Y, et al. Mechanisms of acupuncture on vascular dementia-A review of animal studies. Neurochem Int. 2017 Jul;107:204–10. PubMed PMID: 28034725.10.1016/j.neuint.2016.12.001Suche in Google Scholar PubMed

[18] Bower JE, Irwin MR. Mind-body therapies and control of inflammatory biology: a descriptive review. Brain Behav Immun. 2016 Jan;51:1–11. PubMed PMID: 26116436. Pubmed Central PMCID: 4679419.10.1016/j.bbi.2015.06.012Suche in Google Scholar PubMed

[19] Pan W, Liu J, Chen X, Wang Q, Wu Y, Bai Y, et al. A practical consensus guideline for the integrative treatment of Parkinson’s disease in Shanghai. China Integr Med Int. 2015;2:56–62. Epub September 12, 201510.1159/000435813Suche in Google Scholar

[20] Mishra L, Singh BB, Dagenais S. Ayurveda: a historical perspective and principles of the traditional healthcare system in India. Altern Ther Health Med. 2001 Mar;7:36–42. PubMed PMID: 11253415.Suche in Google Scholar PubMed

[21] Manyam BV. Paralysis agitans and levodopa in “Ayurveda”: ancient Indian medical treatise. Move Disorders off J Move Disord Soc. 1990;5:47–48. PubMed PMID: 2404203.10.1002/mds.870050112Suche in Google Scholar

[22] Ovallath S, Deepa P. The history of Parkinsonism: descriptions in ancient Indian medical literature. Move Disorders off J Move Disord Soc. 2013 May;28:566–68. PubMed PMID: 23483637.10.1002/mds.25420Suche in Google Scholar

[23] Vaidya AB, Rajagopalan TG, Mankodi NA, Antarkar DS, Tathed PS, Purohit AV, et al. Treatment of Parkinson’s disease with the cowhage plant-Mucuna pruriens Bak. Neurol India. 1978 Dec;26:171–76. PubMed PMID: 753996.Suche in Google Scholar PubMed

[24] Vaidya RA, Sheth AR, Aloorkar SD, Rege NR, Bagadia VN, Devi PK, et al. The inhibitory effect of the cowhage plant-Mucuna pruriens-and L-dopa on chlorpromazine-induced hyperprolactinaemia in man. Neurol India. 1978 Dec;26:177–78. PubMed PMID: 753997.Suche in Google Scholar PubMed

[25] Damodaran M, Ramaswamy R. Isolation of l-3:4-dihydroxyphenylalanine from the seeds of Mucuna pruriens. Biochem J. 1937 Dec;31:2149–52. PubMed PMID: 16746556. Pubmed Central PMCID: 1267191.10.1042/bj0312149Suche in Google Scholar PubMed

[26] Hussain GaM B. Mucuna pruriens Proves more effective than L-DOPA in Parkinson’s disease animal model. Phytotherapy Res. 1997;11:419–23.10.1002/(SICI)1099-1573(199709)11:6<419::AID-PTR120>3.0.CO;2-QSuche in Google Scholar

[27] Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, et al. Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004 Dec;75:1672–77. PubMed PMID: 15548480. Pubmed Central PMCID: 1738871.10.1136/jnnp.2003.028761Suche in Google Scholar PubMed PubMed Central

[28] Hornykiewicz O. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent. Amino Acids. 2002;23:65–70. PubMed PMID: 12373520.10.1007/s00726-001-0111-9Suche in Google Scholar PubMed

[29] Ni M, Mooney K, Signorile JF. Controlled pilot study of the effects of power yoga in Parkinson’s disease. Complement Ther Med. 2016 Apr;25:126–31. PubMed PMID: 27062960.10.1016/j.ctim.2016.01.007Suche in Google Scholar PubMed

[30] Roland KP. Applications of yoga in Parkinson’s disease: a systematic literature review. J Parkinsonism Restless Legs Syndrome. 2014;4:1–8.10.2147/JPRLS.S40800Suche in Google Scholar

[31] Schmalzl L, Kerr CE. Editorial: neural mechanisms underlying movement-based embodied contemplative practices. Front Hum Neurosci. 2016;10:169. PubMed PMID: 27199700. Pubmed Central PMCID: 4844845.10.3389/fnhum.2016.00169Suche in Google Scholar PubMed PubMed Central

[32] Horowski R, Horowski L, Vogel S, Poewe W, Kielhorn FW. An essay on Wilhelm von Humboldt and the shaking palsy: first comprehensive description of Parkinson’s disease by a patient. Neurology. 1995 Mar;45:565–68. PubMed PMID: 7898719.10.1212/WNL.45.3.565Suche in Google Scholar PubMed

[33] Goetz CG. The history of Parkinson’s disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med. 2011 Sep;1:a008862. PubMed PMID: 22229124. Pubmed Central PMCID: 3234454.10.1101/cshperspect.a008862Suche in Google Scholar PubMed PubMed Central

[34] Gowers WR. A manual of diseases of the nervous system. Philadelphia, PA: Blakiston Son and Co., 1888.10.2307/1411377Suche in Google Scholar

[35] Critchley M. Sir William Gowers, 1845–1915; a biographical appreciation. London: Heinemann, 1949: 118.Suche in Google Scholar

[36] Lees AJ, Selikhova M, Andrade LA, Duyckaerts C. The black stuff and Konstantin Nikolaevich Tretiakoff. Move Disorders off J Move Disord Soc. 2008 Apr 30;23:777–83. PubMed PMID: 18383531.10.1002/mds.21855Suche in Google Scholar PubMed

[37] Vogt M. The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J Physiol. 1954 Mar 29;123:451–81. PubMed PMID: 13152692. Pubmed Central PMCID: 1366219.10.1113/jphysiol.1954.sp005064Suche in Google Scholar PubMed PubMed Central

[38] Greenfield JG. Pathology of Parkinson’s disease. In: Critchley M, editor. James Parkinson. London: MacMillan, 1955: 219–43.Suche in Google Scholar

[39] Ehringer HHO. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr. 1960;38:1236–39.10.1007/BF01485901Suche in Google Scholar

[40] Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997 Aug 28;388:839–40. PubMed PMID: 9278044.10.1038/42166Suche in Google Scholar PubMed

[41] Braak H, Del Tredici K, Rub U, De Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003 Mar-Apr;24:197–211. PubMed PMID: 12498954. Epub 2002/12/25.eng.10.1016/S0197-4580(02)00065-9Suche in Google Scholar PubMed

[42] Burke RE, Dauer WT, Vonsattel JP. A critical evaluation of the Braak staging scheme for Parkinson’s disease. Ann Neurol. 2008 Nov;64:485–91. PubMed PMID: 19067353. Epub 2008/ 12/11.eng.10.1002/ana.21541Suche in Google Scholar PubMed PubMed Central

[43] Jellinger KA. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta. 2009 Jul;1792:730–40. PubMed PMID: 18718530.10.1016/j.bbadis.2008.07.006Suche in Google Scholar PubMed

[44] Holtz PHR, Lüdtke K. Fermentativer Abbau von LDioxyphenylalanin (Dopa) durch Niere. Naunyn-Schmiedeberg’s. Arch Exp Path Pharmak. 1938;191:87–118.10.1007/BF01994628Suche in Google Scholar

[45] Fahn S. The medical treatment of Parkinson disease from James Parkinson to George Cotzias. Move Disorders off J Move Disord Soc. 2015;30:4–18 (Epub was Dec 2014).10.1002/mds.26102Suche in Google Scholar PubMed

[46] Montagu KA. Catechol compounds in rat tissues and in brains of different animals. Nature. 1957 Aug 3;180:244–45. PubMed PMID: 13451690.10.1038/180244a0Suche in Google Scholar PubMed

[47] Raab W, Gigee W. Concentration and distribution of “encephalin” in the brain of humans and animals. Proc Soc Exp Biol Med Soc Exp Biol Med. 1951 Jan;76:97–100. PubMed PMID: 14816401.10.3181/00379727-76-18398Suche in Google Scholar PubMed

[48] Weil-Malherbe H, Bone AD. Intracellular distribution of catecholamines in the brain. Nature. 1957 Nov 16;180:1050–51. PubMed PMID: 13483601.10.1038/1801050a0Suche in Google Scholar PubMed

[49] Holtz PBH, Westermann E, Wezler E. Beeinflussung der Evipannarkose durch Reserpin. Iproniazid Biogene Amine Arch Exp Path Pharmakol. 1957;231:333–48.10.1007/BF00246936Suche in Google Scholar

[50] Bertler A, Rosengren E. Occurrence and distribution of dopamine in brain and other tissues. Experientia. 1959 Jan 15;15:10–11. PubMed PMID: 13619664.10.1007/BF02157069Suche in Google Scholar PubMed

[51] Hornykiewicz O. The action of dopamine on the arterial blood pressure of the guinea-pig. Br J Pharmacol Chemother. 1958 Mar;13:91–94. PubMed PMID: 13523142. Pubmed Central PMCID: 1481693.10.1111/j.1476-5381.1958.tb00197.xSuche in Google Scholar PubMed

[52] Sano I, Gamo T, Kakimoto Y, Taniguchi K, Takesada M, Nishinuma K. Distribution of catechol compounds in human brain. Biochim Biophys Acta. 1959 Apr;32:586–87. PubMed PMID: 14441532.10.1016/0006-3002(59)90652-3Suche in Google Scholar PubMed

[53] Carlsson A, Lindqvist M, Magnusson T, Waldeck B. On the presence of 3-hydroxytyramine in brain. Science. 1958 Feb 28;127:471. PubMed PMID: 13529006.10.1126/science.127.3296.471Suche in Google Scholar PubMed

[54] Carlsson A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev. 1959 Jun;11:490–93. PubMed PMID: 13667431.10.1016/S0031-6997(25)07428-9Suche in Google Scholar PubMed

[55] Carlsson A. A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture. Biosci Rep. 2001 Dec;21:691–710. PubMed PMID: 12166820.10.1023/A:1015556204669Suche in Google Scholar PubMed

[56] Lees AJ, Tolosa E, Olanow CW. Four pioneers of L-dopa treatment: arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr. Move Disorders off J Move Disord Soc. 2014 Dec 8. PubMed PMID: 25488030.10.1002/mds.26120Suche in Google Scholar

[57] Foley P. The L-DOPA story revisited. Further surprises to be expected?. J Neural Transm Supplementum. 2000;60:1–20. PubMed PMID: 11205132.10.1007/978-3-7091-6301-6_1Suche in Google Scholar

[58] Sano I. Biochemistry of the extrapyramidal system Shinkei Kennkyu No Shinpo, Advances in Neurological Sciences. (ISSN 0001-8724) Tokyo, October 1960;5:42-48. Parkinsonism Relat Disord. 2000 Jan;6:3–6. PubMed PMID: 18591145.10.1016/S1353-8020(99)00046-2Suche in Google Scholar

[59] Birkmayer W, Hornykiewicz O. Der L-Dioxyphenylalanin (=DOPA)-Effekt bei der Parkinson-Akinese. Wien Klin Wochenschr. 1961;73:787–88.Suche in Google Scholar

[60] Barbeau A, Murphy GF, Sourkes TL. Excretion of dopamine in diseases of basal ganglia. Science. 1961 May 26;133:1706–07. PubMed PMID: 13686753.10.1126/science.133.3465.1706-aSuche in Google Scholar PubMed

[61] Barbeau A, Sourkes TL, Murphy GF. Les catécholamines dans la maladie de Parkinson. In: De Ajuriaguerra J, editor. Monoamines et Système Nerveux Central. Geneva: Georg et Cie, 1962: 247–62.Suche in Google Scholar

[62] Hornykiewicz O. Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin (3-Hydroxytyramin) in the Substantia nigra des normalen und Parkinsonkranken Menschen. Wien Klin Wochenschr. 1963;75:309–12.Suche in Google Scholar

[63] Hornykiewicz O. The discovery of dopamine deficiency in the parkinsonian brain. J Neural Transm Supplementum. 2006;70:9–15. PubMed PMID: 17017502.10.1007/978-3-211-45295-0_3Suche in Google Scholar PubMed

[64] Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of Parkinsonism. N Engl J Med. 1967 Feb 16;276:374–79. PubMed PMID: 5334614.10.1056/NEJM196702162760703Suche in Google Scholar PubMed

[65] Cotzias GC, Papavasiliou PS, Gellene R. Modification of Parkinsonism–chronic treatment with L-dopa. N Engl J Med. 1969 Feb 13;280:337–45. PubMed PMID: 4178641.10.1056/NEJM196902132800701Suche in Google Scholar PubMed

[66] Tang LC. A personal and scientific biography of Dr George C. Cotzias. Neurotoxicology. 1984 Spring;5:5–12. PubMed PMID: 6425745.Suche in Google Scholar

[67] Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM. Treatment of Parkinsonism with levodopa. Arch Neurol. 1969 Oct;21:343–54. PubMed PMID: 5820999.10.1001/archneur.1969.00480160015001Suche in Google Scholar PubMed

[68] Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17:427–42. PubMed PMID: 6067254.10.1212/WNL.17.5.427Suche in Google Scholar PubMed

[69] Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–42.10.1212/WNL.17.5.427Suche in Google Scholar PubMed

[70] Fahn S. A new look at levodopa based on the ELLDOPA study. J Neural Transm Supplementum. 2006;70:419–26. PubMed PMID: 17017562.10.1007/978-3-211-45295-0_63Suche in Google Scholar PubMed

Received: 2016-07-12
Accepted: 2018-03-22
Published Online: 2018-05-08

© 2018 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Review
  2. Active phytoconstituents for diabetes management: A review
  3. Pharmacological potentials of betalains
  4. The effects of fennel on menstrual bleeding: A systematic review and meta-analysis
  5. Use of natural products for oral hygiene maintenance: revisiting traditional medicine
  6. Antimicrobial properties of terrestrial snail and slug mucus
  7. Historical and cross-cultural perspectives on Parkinson’s disease
  8. The effects of Sahaja Yoga meditation on mental health: a systematic review
  9. Preclinial Studies
  10. Antidiabetic and protective effects of the aqueous extract of Arbutus unedo L. in streptozotocin-nicotinamide-induced diabetic mice
  11. Phytochemical profile, antimicrobial, antioxidant and antiobesity activities of Scolymus angiospermus Gaertn. Four fractions from Jericho/Palestine
  12. Evaluating of β-carotene role in ameliorating of favism-induced disturbances in blood and testis
  13. Subchronic oral toxicity study of Habb-e-Suranjan in albino Wistar rats
  14. 10.1515/jcim-2017-0117
  15. Clinical Studies
  16. Beneficial effect of ghee consumption over mustard oil on lipid profile: A study in North Indian adult population
  17. Diet enriched with fresh coconut decreases blood glucose levels and body weight in normal adults
  18. Effect of prenatal recommendations of Traditional Persian Medicine on obstetric outcomes: a randomized clinical trial
  19. Is fish oil supplementation effective on maternal serum FBS, oral glucose tolerance test, hemoglobin and hematocrit in low risk pregnant women? A triple-blind randomized controlled trial
  20. Efficacy of forced right nostril breathing and selected yogasanas on female obese college students
https://doi.org/10.1515/jcim-2016-0065
Schlagwörter für diesen Artikel
alternative medicine; ayurvedic medicine; history of medicine; Parkinson’s disease; therapeutics; traditional Chinese medicine

Artikel in diesem Heft

  1. Review
  2. Active phytoconstituents for diabetes management: A review
  3. Pharmacological potentials of betalains
  4. The effects of fennel on menstrual bleeding: A systematic review and meta-analysis
  5. Use of natural products for oral hygiene maintenance: revisiting traditional medicine
  6. Antimicrobial properties of terrestrial snail and slug mucus
  7. Historical and cross-cultural perspectives on Parkinson’s disease
  8. The effects of Sahaja Yoga meditation on mental health: a systematic review
  9. Preclinial Studies
  10. Antidiabetic and protective effects of the aqueous extract of Arbutus unedo L. in streptozotocin-nicotinamide-induced diabetic mice
  11. Phytochemical profile, antimicrobial, antioxidant and antiobesity activities of Scolymus angiospermus Gaertn. Four fractions from Jericho/Palestine
  12. Evaluating of β-carotene role in ameliorating of favism-induced disturbances in blood and testis
  13. Subchronic oral toxicity study of Habb-e-Suranjan in albino Wistar rats
  14. 10.1515/jcim-2017-0117
  15. Clinical Studies
  16. Beneficial effect of ghee consumption over mustard oil on lipid profile: A study in North Indian adult population
  17. Diet enriched with fresh coconut decreases blood glucose levels and body weight in normal adults
  18. Effect of prenatal recommendations of Traditional Persian Medicine on obstetric outcomes: a randomized clinical trial
  19. Is fish oil supplementation effective on maternal serum FBS, oral glucose tolerance test, hemoglobin and hematocrit in low risk pregnant women? A triple-blind randomized controlled trial
  20. Efficacy of forced right nostril breathing and selected yogasanas on female obese college students
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 20.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jcim-2016-0065/html
Button zum nach oben scrollen